Document Detail


Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers.
MedLine Citation:
PMID:  22740189     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Malaria is one of the most common and serious infectious diseases in the tropics and subtropics. For high-risk travelers to endemic regions, malaria chemoprophylaxis is recommended. Internationally, atovaquone-proguanil (A/P), mefloquine (MEF), or doxycycline (DOX) are the prescribed malaria chemoprophylactic drugs. However, A/P and DOX are not approved in Japan. Therefore, the data on A/P for malaria chemoprophylaxis in Japanese travelers are not clear. We analyzed questionnaire survey data obtained in Hibiya Clinic to assess the safety and tolerability of A/P and compare them with those of MEF for non-immune Japanese travelers. A/P was given to 278 travelers and MEF to 38 travelers. The mean duration of each prophylaxis is for 20.0 ± 9.6 and 59.0 ± 15.9 days, respectively. Nine travelers discontinued prophylaxis: 5 in the A/P prescribed group (A/P group) and 4 in the MEF prescribed group (MEF group), and the rate of discontinuation was significantly less in the A/P group. The frequency of adverse events was significantly less in the A/P group than in the MEF group [52 cases (18.8 %) vs. 14 cases (36.8 %), respectively]. In particular, the frequency of psychoneurotic adverse events was significantly less in the A/P group. These results suggest that A/P is better tolerated and has fewer adverse events than MEF in non-immune Japanese travelers.
Authors:
Tetsuro Kato; Joji Okuda; Daisuke Ide; Katsushi Amano; Yutaka Takei; Yuko Yamaguchi
Related Documents :
17418729 - Perioperative serum interleukins in neonates with hypoplastic left-heart syndrome and t...
17272439 - Intraoperative red blood-cell salvage in revision hip surgery. a case-matched study.
16183679 - Activated recombinant factor vii after cardiopulmonary bypass reduces allogeneic transf...
20081519 - Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures ...
20630919 - Dutch perfusion incident survey.
9492179 - Production of tnfalpha and il-6 by activated whole blood from hiv-1 infected patients d...
17418729 - Perioperative serum interleukins in neonates with hypoplastic left-heart syndrome and t...
19813249 - High incidence of hearing loss in long-term survivors of multisystem langerhans cell hi...
9436149 - The step phenomenon in the recovery of vision with spinal manipulation: a report on two...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-29
Journal Detail:
Title:  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy     Volume:  -     ISSN:  1437-7780     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9608375     Medline TA:  J Infect Chemother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Hibiya-Clinic, 1-5-2 Yurakucho, Chiyoda-ku, Tokyo, 100-0006, Japan, katetsu@av5.mopera.ne.jp.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Decreasing mortality after femoral neck fracture treated with bipolar hemiarthroplasty during the la...
Next Document:  Strategic assay deployment (SAD) as a method for countering analytical bottlenecks in high throughpu...